20.42
Doximity Inc stock is traded at $20.42, with a volume of 2.18M.
It is down -0.15% in the last 24 hours and down -1.97% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$20.45
Open:
$20.88
24h Volume:
2.18M
Relative Volume:
0.56
Market Cap:
$3.67B
Revenue:
$644.86M
Net Income/Loss:
$196.05M
P/E Ratio:
20.81
EPS:
0.9812
Net Cash Flow:
$317.50M
1W Performance:
-5.11%
1M Performance:
-1.97%
6M Performance:
-49.74%
1Y Performance:
-66.33%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
20.42 | 3.67B | 644.86M | 196.05M | 317.50M | 0.9812 |
|
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Form 4 Doximity Inc For: 24 July By Investing.com - Investing.com Nigeria
DOCS|Doximity Inc|Price:20.410|Chg%:-0.040 - TradingKey
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity, Inc. (DOCS) Options Chain - Yahoo! Finance Canada
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance Australia
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Doximity, Inc. (DOCS) Latest Stock News & Headlines - Yahoo! Finance Canada
2 Reasons to Like DOCS (and 1 Not So Much) - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $22 - Moomoo
Doximity Chief Accounting Officer Sitaram Siddharth disposes of 1,732 shares worth $38,150.64 - Bitget
Sparta 24 Ltd. Takes $2.94 Million Position in Doximity, Inc. $DOCS - MarketBeat
How Doximity Inc. Class A (DOCS) Affects Rotational Strategy Timing - Stock Traders Daily
A Look at Doximity Inc (DOCS) After 3.1% Decline -- GF Value $49 - GuruFocus
Zoom, AppLovin, and Doximity Shares Are Falling, What You Need To Know - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - Yahoo Finance
Reasons to Retain Doximity Stock in Your Portfolio for Now - Yahoo Finance
Is AI ready to take over your prescriptions? Doctors are wary of Utah's automated refill program - AOL.com
Is Doximity (DOCS) Cheap As Its Clinical AI Tool Tops Safety Benchmark? - Sahm
AI has taken over prescription refills in Utah. Some doctors are wary - AOL.com
Medical watchdog reveals issues with recent medical student reports - AOL.com
Press Release: Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 - Moomoo
Doximity to report fiscal Q1 2027 results on August 6 - scanx.trade
Doximity Sets Aug. 6 Webcast to Discuss Its June Quarter - Stock Titan
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026 - Yahoo Finance
Doximity, Inc. ($DOCS) CEO 2026 Pay Revealed - Quiver Quantitative
DOCS (NYSE: DOCS) files Form 144 for 1,732-share sale - Stock Titan
Doximity (NYSE:DOCS) Attracts Renewed Market Interest - Kalkine Media
Doximity Outranks OpenEvidence, Frontier Models in Independent S - GuruFocus
11,000 Physician Experts Helped Improve Doximity's Clinical AI - Stock Titan
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety - Mid Florida Newspapers
Form DEF 14A Doximity For: 15 July By Investing.com - Investing.com Nigeria
Doximity | DEF 14A: Definitive information statements - Moomoo
Doximity (NYSE: DOCS) sets 2026 virtual meeting, pay and auditor votes - Stock Titan
Doximity (NYSE:DOCS) Upgraded at Zacks Research - MarketBeat
Doximity, Inc. SEC Filing (Jul 15, 2026) - Stock Titan
Form 4 Doximity Inc For: 14 July By Investing.com - Investing.com Nigeria
Doximity (DOCS) director receives 9,750 RSUs as committee voids part of prior grant - Stock Titan
Equity grant: Doximity (NYSE: DOCS) gives 21,314 RSUs to director - Stock Titan
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 12.66% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Doximity (DOCS) Q4 2026 earnings summary - Quartr
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Winners And Losers Of Q1: Doximity (NYSE:DOCS) Vs The Rest Of The Vertical Software Stocks - Yahoo Finance
OpenEvidence Launches EvidenceGrade™, Empowering Physicians To See the Strength of Cited Evidence Beneath Each AI Answer - AOL.com
Swedbank AB Acquires 929,576 Shares of Doximity, Inc. $DOCS - MarketBeat
Hsbc Holdings PLC Raises Position in Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) up 11.2% since last earnings report: Can it continue? - MSN
Doximity Inc (NYSE:DOCS) Passes Quality Investing Screen with Strong Profitability and Zero Debt - ChartMill
RBC Capital Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $28 - Moomoo
Doximity Company Profile & Introduction - Moomoo
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):